Загрузка...

Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is considered to be a hepatic manifestation of metabolic syndrome, and its incidence is rapidly increasing worldwide. It is currently the most common chronic liver disease. NASH can progress to liver cirrhosis and hepatocel...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :World J Gastroenterol
Главные авторы: Takahashi, Yoshihisa, Sugimoto, Keiichiro, Inui, Hiroshi, Fukusato, Toshio
Формат: Artigo
Язык:Inglês
Опубликовано: Baishideng Publishing Group Inc 2015
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4385525/
https://ncbi.nlm.nih.gov/pubmed/25852263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i13.3777
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!